Synthetic peptides for a rubella vaccine
CA 2128407 C · Owner: Gillam, Shirley · Inventors: Ou, Dawei; Tingle, Aubrey; Chong, Pele
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Synthetic peptides have an amino acids sequence corresponding to at least one antigenic determinant of at least one protein, usually a structural protein, particularly the E1 E2 or C proteins, of , rubella virus (RV) are used as is, in hybrid or chimeric, tandem T-B form in lipidated form, linked to a carrier molecule and/or polymerized to form molecular aggregates in vaccines, against rubella. Analogs of peptides which are human T-cell determinants are used to treat rubella-associated autoimmune disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 20, 1993 and granted April 9, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 20, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 20, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.